Sir Chris Hoy, the six-time Olympic gold medallist, has provided an update on his stage four prostate cancer diagnosis, stating he is responding well to treatment and remains positive.
Hoy, 50, revealed his diagnosis in late 2024, at which point the incurable cancer had spread to his bones, leading to a prognosis of two to four years. He undergoes tests every three to six months, with more frequent monitoring if areas of concern arise. These check-ups can reveal increases in his prostate-specific antigen (PSA) levels, indicating increased cancer activity.
He has adjusted his approach to receiving test results, preferring virtual consultations over in-person meetings to avoid misinterpreting doctors' body language. Hoy has become a vocal advocate for prostate cancer awareness, emphasizing the need for men to understand their risk.
Prostate cancer is the most common cancer among men in the UK, with approximately 63,000 new cases and 12,000 deaths annually. Despite this, there is no national screening program, unlike for breast, bowel, or lung cancer. Hoy's initial symptoms appeared in September 2023 as shoulder pain, which led to the discovery of a tumor. Within days, he learned the primary cancer was in his prostate and had metastasized to his shoulder, hips, ribs, and spine.
Hoy has questioned the government's reluctance to implement a broader screening program, citing the potential for unnecessary treatments as a reason often given for the absence of such a system. He pointed to France as an example of a country with a screening system, stating, "I don't know why we don't. It just doesn't make sense."
In parallel, a limited prostate cancer screening drive is set to launch next year, inviting around 1,500 men aged 45 to 61 who have a specific gene mutation and a family history of certain cancers. This initiative is part of a broader campaign, supported by publications like the Daily Mail, aimed at reducing prostate cancer deaths.
Separately, the NHS has announced a major prostate cancer research program that will contact 500,000 men who have or are currently living with the disease. The initiative aims to improve diagnosis, treatment, and understanding of treatment side effects, with backing from public figures like Stephen Fry. Hoy also shared that exercise has been a significant part of his coping strategy, noting studies that suggest it can enhance cancer medication efficacy and improve time to relapse, likening its potential benefits to a "miracle drug" if it were in pill form.